Brain Tumor Centers

Find U.S. facilities with actively recruiting interventional brain-tumor trials. Choose one state at a time; facility details load only after you select a facility.

Back to facilities in Washington

University of Washington Medical Center

Seattle, Washington 98195

Recruiting trials at this facility

• CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL) (NCT03328078)
  Relapsed Hematologic Malignancy, Refractory Hematologic Malignancy, Relapsed Primary Central Nervous System Lymphoma, Refractory Primary Central Nervous System Lymphoma